HESG OTC
Health Sciences Group, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: +0.0%
1Y: -90.0%
3Y: -99.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±9874.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$358K
+0.0% ▲
5Y CAGR: +1.0%
Gross Profit
$25K
+0.0% ▲
5Y CAGR: -21.2%
Operating Income
-$54K
+0.0% ▲
Net Income
-$54K
+0.0% ▲
EPS (Diluted)
$-0.03
+0.0% ▲
EBITDA
-$45K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2002 | FY2003 | FY2004 | FY2005 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $6M | $5M | $67K | $60K | $358K |
| YoY Growth | +1520.2% | -3.1% | -98.7% | -10.5% | +0.0% |
| Cost of Revenue | $4M | $4M | $21K | $37K | $333K |
| Gross Profit | $1M | $998K | $47K | $23K | $25K |
| Gross Margin | 26.9% | 18.6% | 69.4% | 38.1% | 7.0% |
| R&D Expenses | $54K | $50K | $7K | $61K | $0 |
| SG&A Expenses | $6M | $4M | $4M | $7M | $80K |
| Operating Expenses | $6M | $5M | $5M | $8M | $80K |
| Operating Income | -$4M | -$4M | -$5M | -$7M | -$54K |
| Operating Margin | -73.7% | -70.9% | -6766.0% | -12440.6% | -15.2% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$4M | -$5M | -$5M | -$6M | -$54K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$7M | -$10M | -$6M | -$54K |
| Net Margin | -77.4% | -138.3% | -15552.6% | -9560.7% | -15.2% |
| EPS (Diluted) | $-0.73 | $-0.76 | $-0.78 | $-0.25 | $-0.03 |
| EBITDA | -$4M | -$2M | -$3M | -$5M | -$45K |
| Shares Outstanding | 6M | 11M | 14M | 25M | 2M |